Drug Design, Development and Therapy (Dec 2017)

Guideline development for the management of gout: role of combination therapy with a focus on lesinurad [Corrigendum]

  • Jones G,
  • Panova E,
  • Day R

Journal volume & issue
Vol. Volume 11
pp. 3589 – 3590

Abstract

Read online

Jones G, Panova E, Day R. Drug Des Devel Ther. 2017;11:3077–3081.On page 3078, Table 1, Abbreviation list, expansion for FBX was incorrectly listed as feboxustat, the correct spelling is febuxostat.Read the original article